Latest Commercialisation News

Carnegie Clean Energy has secured $2.5 million through a share placement, attracting new overseas investors to fund expansion of its CETO wave energy technology at BiMEP in Spain and commercial activities in Europe and the US.

Proteomics International has locked in a three-year exclusive distribution deal with Healius, leveraging its extensive pathology network to roll out its Promarker® diagnostic tests nationally from FY27.

PainChek has received a $1.123 million R&D tax incentive refund for FY2025, reinforcing its cash reserves and underpinning ongoing development of AI pain assessment algorithms and US market validation.

Mandrake Resources has secured key agreements to produce lithium brine from its Utah project and plans a significant drilling campaign in Australia, supported by strong cash reserves.

Nanoveu’s ECS-DoT edge-AI chip has proven its mettle in live drone trials with up to 51% energy efficiency gains, while the acquisition of Spinoff Robotics adds proprietary drone platforms and engineering talent to accelerate commercialisation.

Ceretas Limited is raising $8 million through an IPO to fund clinical trials and development of its novel therapeutic ultrasound device targeting Alzheimer’s disease symptoms.

Recce Pharmaceuticals secured a non-binding term sheet with a major Middle Eastern pharma for its diabetic foot infection treatment and raised A$4 million to fund pivotal Phase 3 trials in Australia and Indonesia.

Lumos Diagnostics is accelerating the rollout of its rapid FebriDx test in the US, with a top 100 urgent care group deploying across 30+ sites and three tier 1 groups validating the test across 230+ locations.

Pure Resources has achieved a key early milestone with Oak Ridge National Laboratory confirming the recovery of heavy rare earth elements from garnet concentrate at its Garnet Hills Project. While still at proof-of-concept stage, this validates the potential for a new source of critical minerals.

Green360 Technologies has locked in a revised supply deal with Boyer Paper Mill that guarantees a minimum 4,000 tonne purchase in FY27 and lifts pricing by 19%, underpinning revenue of up to $2.9 million and supporting operational efficiencies at its Pittong plant.

AFT Pharmaceuticals has received tentative US FDA approval for its Scomara cream to treat Facial Angiofibromas in Tuberous Sclerosis, but US commercialisation is postponed until 2029 due to orphan drug exclusivity. The approval bolsters regulatory prospects in other key markets where AFT anticipates competitive advantages.

Cadoux Ltd and the SAFELOOP consortium have surpassed key performance and recycling targets in lithium-ion battery development, marking a world-first in commercial-scale use of recycled active materials enhanced by Cadoux's premiumHPA®. This breakthrough advances the pathway to gigafactory production and strengthens Cadoux's position in the EV battery supply chain.